BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7971613)

  • 1. Use of NSAIDs. An assault on the upper gastrointestinal tract.
    Heigh RI
    Postgrad Med; 1994 Nov; 96(6):63-8. PubMed ID: 7971613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
    Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes].
    Teixeira AV
    Acta Med Port; 1995 Sep; 8(9):517-21. PubMed ID: 7484272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa.
    Laine L
    Gastroenterol Clin North Am; 1993 Mar; 22(1):117-25. PubMed ID: 8449561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Tsay SH; Li AS; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(26):1000-4. PubMed ID: 10370655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: synergy or null effect?
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S402-3. PubMed ID: 11570032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins, NSAIDs, and cytoprotection.
    Wallace JL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):631-41. PubMed ID: 1516961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disadvantageous effects of nonsteroidal anti-inflammatory drugs on the alimentary tract.
    Cichoz-Lach H; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):403-8. PubMed ID: 12898870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
    Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
    J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multisystem adverse effects of NSAID therapy.
    James DS
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S1-7. PubMed ID: 10643174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastropathy caused by nonsteroidal anti-inflammatory agents].
    Márquez-Murillo MF; Suazo J; Poo JL
    Rev Invest Clin; 1997; 49(3):241-54. PubMed ID: 9380979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?
    Jones NL; Sherman P; Wang B; Inman RD
    Bull Rheum Dis; 1997 Dec; 46(8):6-8. PubMed ID: 9409058
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
    Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
    Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.